176 related articles for article (PubMed ID: 29545471)
1. Economic burden of HIV and TB/HIV coinfection in a middle-income country: a costing analysis alongside a pragmatic clinical trial in Brazil.
Teixeira de Siqueira-Filha N; Militao de Albuquerque MF; Cunha Rodrigues L; Legood R; Costa Santos A
Sex Transm Infect; 2018 Sep; 94(6):463-469. PubMed ID: 29545471
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of tuberculosis and latent tuberculosis in people living with HIV in Brazil: a cost study from the patient perspective.
de Siqueira Filha NT; de Fatima Pessoa Militao de Albuquerque M; Legood R; Rodrigues L; Santos AC
Public Health; 2018 May; 158():31-36. PubMed ID: 29533835
[TBL] [Abstract][Full Text] [Related]
3. Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study.
Pipitò L; Ricci ED; Maggi P; De Socio GV; Pellicano GF; Trizzino M; Rubino R; Lanzi A; Crupi L; Capriglione I; Squillace N; Nunnari G; Di Biagio A; Bonfanti P; Cascio A;
Viruses; 2024 May; 16(5):. PubMed ID: 38793658
[TBL] [Abstract][Full Text] [Related]
4. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
5. Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan.
Kawatsu L; Kaneko N; Imahashi M; Kamada K; Uchimura K
AIDS Res Ther; 2022 Dec; 19(1):60. PubMed ID: 36463211
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
[TBL] [Abstract][Full Text] [Related]
7. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
[TBL] [Abstract][Full Text] [Related]
8. Hospital length of stay and cost burden of HIV, tuberculosis, and HIV-tuberculosis coinfection among pregnant women in the United States.
Falana A; Akpojiyovwi V; Sey E; Akpaffiong A; Agumbah O; Chienye S; Banks J; Jones E; Spooner KK; Salemi JL; Olaleye OA; Onyiego SD; Salihu HM
Am J Infect Control; 2018 May; 46(5):564-570. PubMed ID: 29108662
[TBL] [Abstract][Full Text] [Related]
9. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV.
Steffen RE; Pinto M; Kritski A; Trajman A
Sci Rep; 2020 Dec; 10(1):21823. PubMed ID: 33311520
[TBL] [Abstract][Full Text] [Related]
12. [Factors associated with TB/HIV coinfection: evidence from notification data in the State of Amazonas, Brazil, 2001-2012].
Magno EDS; Saraceni V; Souza AB; Magno RDS; Saraiva MDGG; Bührer-Sékula S
Cad Saude Publica; 2017 Jun; 33(5):e00019315. PubMed ID: 28614446
[TBL] [Abstract][Full Text] [Related]
13. Screening for latent tuberculous infection in people living with HIV infection in Auckland, New Zealand.
Gow N; Briggs S; Nisbet M
Int J Tuberc Lung Dis; 2017 Sep; 21(9):1008-1012. PubMed ID: 28826450
[TBL] [Abstract][Full Text] [Related]
14. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.
Poudel AN; Newlands D; Simkhada P
BMC Health Serv Res; 2017 Jan; 17(1):76. PubMed ID: 28118830
[TBL] [Abstract][Full Text] [Related]
17. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of tuberculosis care for patients and households in Africa: a systematic review.
Ukwaja KN; Modebe O; Igwenyi C; Alobu I
Int J Tuberc Lung Dis; 2012 Jun; 16(6):733-9. PubMed ID: 22410546
[TBL] [Abstract][Full Text] [Related]
19. Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area.
Capocci S; Smith C; Morris S; Bhagani S; Cropley I; Abubakar I; Johnson M; Lipman M
Eur Respir J; 2015 Jul; 46(1):165-74. PubMed ID: 25882810
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.
Cui Z; Lin M; Nie S; Lan R
PLoS One; 2017; 12(3):e0173976. PubMed ID: 28358846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
